Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 50
Filtrar
Más filtros

País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
J Pediatr ; 206: 232-239.e3, 2019 03.
Artículo en Inglés | MEDLINE | ID: mdl-30522751

RESUMEN

OBJECTIVE: To assess the sustainability of the benefits relative to usual care of a medical home providing comprehensive care for high-risk children with medical complexity (≥2 hospitalizations or ≥1 pediatric intensive care unit [PICU] admission in the year before enrollment) after we made comprehensive care our standard practice and expanded the program. STUDY DESIGN: We conducted pre-post comparisons of the rate of children with serious illness (death, PICU admission, or >7-day hospitalization) and health-system costs observed after program expansion (March 2014-June 2015) to those during the clinical trial (March 2011-August 2013) for each of the trial's treatment groups (usual care, n = 96, and comprehensive care, n = 105; primary analyses), and among all children given comprehensive care (nPost-trial = 233, including trial usual care children who transitioned to comprehensive care post-trial and newly enrolled medically complex children, and nTrial = 105; secondary analyses). We also analyzed the findings for the trial patients as a 2-phase stepped-wedge study. RESULTS: In intent-to-treat analyses, rates of children with serious illness and costs were reduced or unchanged post-trial vs trial for the trial's usual care group (rate ratio [RR], 0.36; 95% CI, 0.20-0.64; cost ratio [CR], 0.68; 95% CI, 0.28-1.68), the trial's comprehensive care group (RR, 0.74; 95% CI, 0.39-1.41; CR, 0.67; 95% CI, 0.51-0.89), and among all children given comprehensive care (RR, 0.97; 95% CI, 0.61-1.52; CR, 0.75; 95% CI, 0.61-0.93). Conservative stepped-wedge analyses identified overall benefits with comprehensive care across both study periods (RR, 0.46; 95% CI, 0.30-0.72; CR, 0.64; 95% CI, 0.43-0.99). CONCLUSIONS: Major benefits of comprehensive care did not diminish with post-trial program expansion.


Asunto(s)
Atención Integral de Salud , Cuidados Críticos , Enfermedad Crítica , Costos de la Atención en Salud , Atención Dirigida al Paciente , Evaluación de Programas y Proyectos de Salud , Niño , Femenino , Hospitalización , Humanos , Masculino
2.
Front Pediatr ; 11: 1118874, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37397151

RESUMEN

Functional abdominal pain disorders (FAPDs) affect up to 25% of children in the United States. These disorders are more recently known as disorders of "brain-gut" interaction. The diagnosis is based on the ROME IV criteria, and requires the absence of an organic condition to explain the symptoms. Although these disorders are not completely understood, several factors have been involved in the pathophysiology including disordered gut motility, visceral hypersensitivity, allergies, anxiety/stress, gastrointestinal infection/inflammation, as well dysbiosis of the gut microbiome. The pharmacologic and non-pharmacologic treatments for FAPDs are directed to modifying these pathophysiologic mechanisms. This review aims to summarize the non-pharmacologic interventions used in the treatment of FAPDs including dietary modifications, manipulation of the gut microbiome (neutraceuticals, prebiotics, probiotics, synbiotics and fecal microbiota transplant) and psychological interventions that addresses the "brain" component of the brain-gut axis (cognitive behavioral therapy, hypnotherapy, breathing and relaxation techniques). In a survey conducted at a large academic pediatric gastroenterology center, 96% of patients with functional pain disorders reported using at least 1 complementary and alternative medicine treatment to ameliorate symptoms. The paucity of data supporting most of the therapies discussed in this review underscores the need for large randomized controlled trials to assess their efficacy and superiority compared to other treatments.

3.
Rev. esp. cardiol. (Ed. impr.) ; 77(3): 189-190, mar. 2024.
Artículo en Español | IBECS (España) | ID: ibc-231053

RESUMEN

A principios de enero de 2023, la revista Nature se hacía eco de un artículo3 subido a finales de diciembre, sin revisión, al servidor bioRxiv. Los autores pidieron a GePeTo que redactara sendos resúmenes de 50 artículos publicados en cinco revistas biomédicas punteras: The Journal of the American Medical Association (JAMA), The New England Journal of Medicine, The British Medical Journal (BMJ), The Lancet y Nature Medicine. Cuando pasaron un detector automático de plagio a estos resúmenes generados por GePeTo, el resultado fue de un 100% de originalidad. A continuación, presentaron estos 50 resúmenes creados con IA y los 50 resúmenes originales publicados en las revistas a un grupo de científicos con experiencia como revisores externos para importantes publicaciones, y les pidieron que trataran de adivinar cuáles eran humanos y cuáles generados por IA. Un chimpancé tecleando a ciegas (o lanzando al aire una moneda) obtendría una tasa esperable de aciertos del 50%. Los revisores humanos identificaron correctamente como obra de GePeTo apenas el 68% de los resúmenes generados, y reconocieron erróneamente como escritos por IA un 14% de los resúmenes originales publicados. No está nada mal, la verdad, para un bot con menos de un mes de vida; todo apunta a que en los años venideros lo irá haciendo cada vez mejor, y que a corto plazo los textos generados por IA serán indistinguibles de los textos humanos para el común de los lectores. (AU)


Asunto(s)
Humanos , Dominios Científicos , /estadística & datos numéricos , Publicaciones Periódicas como Asunto
4.
EGEMS (Wash DC) ; 7(1): 51, 2019 Sep 30.
Artículo en Inglés | MEDLINE | ID: mdl-31646151

RESUMEN

OBJECTIVE: To implement a quality improvement based system to measure and improve data quality in an observational clinical registry to support a Learning Healthcare System. DATA SOURCE: ImproveCareNow Network registry, which as of September 2019 contained data from 314,250 visits of 43,305 pediatric Inflammatory Bowel Disease (IBD) patients at 109 participating care centers. STUDY DESIGN: The impact of data quality improvement support to care centers was evaluated using statistical process control methodology. Data quality measures were defined, performance feedback of those measures using statistical process control charts was implemented, and reports that identified data items not following data quality checks were developed to enable centers to monitor and improve the quality of their data. PRINCIPAL FINDINGS: There was a pattern of improvement across measures of data quality. The proportion of visits with complete critical data increased from 72 percent to 82 percent. The percent of registered patients improved from 59 percent to 83 percent. Of three additional measures of data consistency and timeliness, one improved performance from 42 percent to 63 percent. Performance declined on one measure due to changes in network documentation practices and maturation. There was variation among care centers in data quality. CONCLUSIONS: A quality improvement based approach to data quality monitoring and improvement is feasible and effective.

5.
J Pediatr Gastroenterol Nutr ; 45(3): 312-8, 2007 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-17873743

RESUMEN

OBJECTIVES: To determine whether long-term low-dose prednisone (LTLDP) therapy has a decelerating effect on growth velocity and whether this therapy is effective in the maintenance of remission in the subgroup of pediatric patients with Crohn disease (CD) who had previously experienced flares on more than 1 occasion when prednisone was discontinued. PATIENTS AND METHODS: A retrospective chart review of patients was done. Our sample consisted of patients 6 to 17 years of age with CD who had received uninterrupted prednisone at an average daily dose of 0.1 to 0.4 mg x kg(-1) x day(-1) for at least 8 weeks. Their heights were plotted on sex-appropriate growth charts at 4 time points: 1 year before LTLDP, at therapy onset, at therapy discontinuation, and 1 year after therapy was discontinued. The height velocities (HVs) were compared with the normal HV established by Tanner. The disease activities of 2 groups were compared: LTLDP plus azathioprine/6-mercaptopurine (AZA/6-MP) and LTLDP alone. RESULTS: One hundred two patients were included. The mean age of our sample was 13.7 +/- 2.7 years (standard deviation). The mean dose of prednisone dose was 0.18 +/- 0.07 mg x kg(-1) x day(-1)), for a mean duration of therapy of 14.4 +/- 7.2 months. Throughout the study, 78% of patients had normal HV. Growth deceleration was seen in 19% of patients with prior normal growth. Of this group, 31% had "catch-up" growth 1 year after prednisone was discontinued; the remaining 69% did not. Catch-up growth was more likely in patients who had reached the expected age peak HV, which is defined as 12.5 years for girls and 13.5 years for boys (P = 0.04). In addition, 6 patients reached the peak HV after LTLDP discontinuation; 13 did not. We found no difference in the maintenance of remission rate between the compared groups. CONCLUSIONS: A minority of our study population had growth deceleration. Age was an important factor for subsequent catch-up growth. LTLDP efficacy to maintain remission was not different from that of LTLDP plus AZA/6-MP; differences in concomitant therapies (eg, antibiotics, infliximab) between the 2 groups were not statistically significant.


Asunto(s)
Antiinflamatorios/uso terapéutico , Enfermedad de Crohn/tratamiento farmacológico , Crecimiento/efectos de los fármacos , Prednisona/efectos adversos , Prednisona/uso terapéutico , Adolescente , Factores de Edad , Antiinflamatorios/efectos adversos , Azatioprina/efectos adversos , Azatioprina/uso terapéutico , Niño , Relación Dosis-Respuesta a Droga , Quimioterapia Combinada , Femenino , Crecimiento/fisiología , Humanos , Inmunosupresores/efectos adversos , Inmunosupresores/uso terapéutico , Masculino , Mercaptopurina/efectos adversos , Mercaptopurina/uso terapéutico , Inducción de Remisión , Estudios Retrospectivos , Factores de Tiempo , Resultado del Tratamiento
6.
Microbiol Spectr ; 5(6)2017 12.
Artículo en Inglés | MEDLINE | ID: mdl-29219108

RESUMEN

The origin of the words transmit and transmission and their derivatives can be traced to the Latin transmittere, in turn formed by prefixing the preposition trans ("across or beyond") to the verb mittere ("to let go or to send"). From the times of Ancient Rome in the 3rd century b.c.e., the Latin word transmissio has been "transmitted" (through Romance languages such as French, Italian, Spanish, and Portuguese) to all the major languages of culture, English among them. And through English, the international language of biomedical science in the 21st century, the term transmission is increasingly present today in some of the most dynamic disciplines of modern natural science, including genomics, molecular microbiology, hospital epidemiology, molecular genetics, biotechnology, evolutionary biology, and systems biology.


Asunto(s)
Biología/historia , Lenguaje , Terminología como Asunto , Transmisión de Enfermedad Infecciosa/historia , Historia del Siglo XV , Historia del Siglo XVI , Historia del Siglo XVII , Historia del Siglo XVIII , Historia del Siglo XIX , Historia del Siglo XX , Historia del Siglo XXI , Historia Antigua , Historia Medieval , Humanos , Disciplinas de las Ciencias Naturales/historia
7.
Int J Surg Case Rep ; 14: 80-4, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26254119

RESUMEN

INTRODUCTION: Glomangiomas are rare, benign tumors derived from the glomus body, typically presenting with the classic triad of pain, tenderness to palpation, and hypersensitivity to cold. Most commonly they present as a solitary lesion in the extremities, especially subungual, but they may present elsewhere. PRESENTATION OF CASE: We describe the case of a large (64mm×59mm×41mm) glomangioma on the anteroinferior aspect of a healthy 49 year old male's knee. Symptoms included constant throbbing pain with intermittent stabbing sensations localized to the mass. The mass was evaluated first by magnetic resonance (MR) imaging and then by histopathology following excision. DISCUSSION: Although rare, clinical diagnosis of glomangiomas may be sufficient in typical cases, however in atypical cases, like the one discussed here, further evaluation is often necessary. Here MR findings were suggestive of a glomangioma with low to intermediate signal strength on T1 and mixed signal strength on T2. Intravenous gadolinium infusion demonstrated marked heterogeneous enhancement of the lesion, as well as serpiginous vascular malformations surrounding the lesion. Histopathology following excision confirmed a benign glomangioma depicting monomorphic small, round eosinophilic cells with minimal atypia which stained positive for smooth muscle actin, and negative for cytokeratin, S-100 and CK-34 via immunohistochemistry. CONCLUSION: The following case report details an atypical presentation of a benign glomangioma anterior to the knee in a patient experiencing chronic minor trauma to the area. Diagnosis was suggested by clinical presentation and MR imaging, and was confirmed histologically.

8.
Crit Ultrasound J ; 7(1): 18, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26589313

RESUMEN

Interest in ultrasound education in medical schools has increased dramatically in recent years as reflected in a marked increase in publications on the topic and growing attendance at international meetings on ultrasound education. In 2006, the University of South Carolina School of Medicine introduced an integrated ultrasound curriculum (iUSC) across all years of medical school. That curriculum has evolved significantly over the 9 years. A review of the curriculum is presented, including curricular content, methods of delivery of the content, student assessment, and program assessment. Lessons learned in implementing and expanding an integrated ultrasound curriculum are also presented as are thoughts on future directions of undergraduate ultrasound education. Ultrasound has proven to be a valuable active learning tool that can serve as a platform for integrating the medical student curriculum across many disciplines and clinical settings. It is also well-suited for a competency-based model of medical education. Students learn ultrasound well and have embraced it as an important component of their education and future practice of medicine. An international consensus conference on ultrasound education is recommended to help define the essential elements of ultrasound education globally to ensure ultrasound is taught and ultimately practiced to its full potential. Ultrasound has the potential to fundamentally change how we teach and practice medicine to the benefit of learners and patients across the globe.

9.
Plast Reconstr Surg ; 114(1): 121-8, 2004 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15220579

RESUMEN

Two-photon confocal microscopy is a new technology useful in nondestructive analysis of tissue. The pattern generated from laser-excited autofluorescence and second harmonic signals can be analyzed to construct a three-dimensional, microanatomical, structural image. The healing of full-thickness guinea pig skin wounds was studied over a period of 28 days using two-photon confocal microscopy. Three-dimensional data were rendered from two-dimensional images and compared with conventional, en face, histologic sections. Two-photon confocal microscopy images show resolution of muscle, fascia fibers, collagen fibers, inflammatory cells, blood vessels, and hair. Although these images do not currently have the resolution of standard histology, the ability to noninvasively acquire three-dimensional images of skin promises to be an important tool in wound-healing studies.


Asunto(s)
Microscopía Confocal/métodos , Cicatrización de Heridas/fisiología , Animales , Femenino , Cobayas , Imagenología Tridimensional/métodos , Microscopía Confocal/instrumentación , Piel/lesiones , Piel/patología
11.
Rev. esp. cardiol. (Ed. impr.) ; 77(5): 361-361, mayo 2024.
Artículo en Español | IBECS (España) | ID: ibc-JHG-66
12.
Rev Esp Cardiol (Engl Ed) ; 71(4): 233, 2018 04.
Artículo en Inglés, Español | MEDLINE | ID: mdl-29587993
13.
Rev. esp. cardiol. (Ed. impr.) ; 76(1): 1-1, Ene-Feb. 2023.
Artículo en Español | IBECS (España) | ID: ibc-214444
14.
Rev. esp. cardiol. (Ed. impr.) ; 76(11): 837-837, Nov. 2023.
Artículo en Español | IBECS (España) | ID: ibc-226964
17.
Rev. esp. cardiol. (Ed. impr.) ; 76(10): 751, Octubre 2023.
Artículo en Español | IBECS (España) | ID: ibc-226133
19.
Rev. esp. cardiol. (Ed. impr.) ; 76(9): 671-671, Sept. 2023. ilus
Artículo en Español | IBECS (España) | ID: ibc-224448
20.
Rev. esp. cardiol. (Ed. impr.) ; 76(3): 139-139, mar, 2023.
Artículo en Español | IBECS (España) | ID: ibc-216580
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA